FDA 483 - University of Texas at Arlington IRB - June 11, 2019

An FDA inspection of the University of Texas at Arlington IRB identified a significant compliance issue. The Institutional Review Board failed to ensure that informed consent documents included a statement notifying subjects of the possibility of FDA inspection of their study records. This deficiency was noted across multiple reviewed protocols.